The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy

MLA

Salma Butt, et al. “The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-in Situ and May Predict Patient Response to Radiotherapy.” Annals of Surgical Oncology, vol. 21, no. 9, Oct. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....94505a9881a32e113b48cb1df17fa1b0&authtype=sso&custid=ns315887.

APA

Salma Butt, Linda Werner Hartman, Karin Jirström, Signe Borgquist, Fredrik Wärnberg, Wenjing Zhou, Rose-Marie Amini, & Talha Butt. (2013). The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy. Annals of Surgical Oncology, 21(9).

Chicago

Salma Butt, Linda Werner Hartman, Karin Jirström, Signe Borgquist, Fredrik Wärnberg, Wenjing Zhou, Rose-Marie Amini, and Talha Butt. 2013. “The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-in Situ and May Predict Patient Response to Radiotherapy.” Annals of Surgical Oncology 21 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....94505a9881a32e113b48cb1df17fa1b0&authtype=sso&custid=ns315887.